---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-030217"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2025-10-02T23:59:59+00:00"
generated_at: "2026-05-17T05:01:27.252127+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioCardia regains Nasdaq compliance; stock continues trading on Capital Market

## Summary
- Received Nasdaq notice on Oct 1, 2025 confirming compliance with Listing Rule 5550(b)(1).
- Company improved balance sheet and raised new capital to meet equity requirements.
- Common stock (BCDA) will continue to trade on Nasdaq Capital Market without interruption.
- Resolution removes previous delisting risk associated with equity deficiency.

## SEC filing metadata
- accession: 0001437749-25-030217
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2025-10-02T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774925030217/0001437749-25-030217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774925030217/bcda20251001_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-030217
- JSON: https://secwatch.observer/filing/0001437749-25-030217.json
- Plain text: https://secwatch.observer/filing/0001437749-25-030217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.